e-learning
resources
Virtual 2021
07.09.2021
Clinical features and new biomarkers of asthma, COPD and chronic cough
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Plasma adiponectin and risk of asthma: observational and Mendelian randomization studies in up to 557,801 individuals
M. Nielsen (Herlev, Denmark), B. Nordestgaard (Herlev, Denmark), M. Benn (Copenhagen, Denmark), Y. Çolak (Herlev, Denmark)
Source:
Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Session:
Clinical features and new biomarkers of asthma, COPD and chronic cough
Session type:
E-poster
Number:
3121
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Nielsen (Herlev, Denmark), B. Nordestgaard (Herlev, Denmark), M. Benn (Copenhagen, Denmark), Y. Çolak (Herlev, Denmark). Plasma adiponectin and risk of asthma: observational and Mendelian randomization studies in up to 557,801 individuals. 3121
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Leptin, adiponectin and asthma: findings from a population-based cohort study
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009
Serum testosterone and asthma outcomes in two large population-based studies
Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Year: 2020
Inflammation biomarkers and risk of pulmonary hypertension: a Mendelian randomization study
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020
Hormonal contraception increases risk of asthma among obese but decreases it among nonobese subjects: a prospective, population-based cohort study
Source: ERJ Open Res 2015; 1: 00026-2015
Year: 2015
A mendelian randomization study of BMI and asthma exacerbations in children
Source: Virtual Congress 2020 – Risk factors for chronic lung diseases
Year: 2020
Circulating leptin in OSA patients – a prospective study
Source: Eur Respir J 2006; 28: Suppl. 50, 413s
Year: 2006
Asthma, obesity and
TNFA
: two international population-based cohort studies
Source: Annual Congress 2008 - Genetic risk factors for asthma and COPD
Year: 2008
The effect of early puberty on asthma in women and men: A Mendelian randomization study
Source: International Congress 2018 – Multiomics studies in epidemiology: what can they tell us?
Year: 2018
Serum 25-hydroxyvitamin D levels and risk of lung cancer and histologic types: a Mendelian randomisation analysis of the HUNT study
Source: Eur Respir J, 51 (6) 1800329; 10.1183/13993003.00329-2018
Year: 2018
Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021
Stability of serum biomarkers and their associations with clinical outcomes in COPD patients and controls: a longitudinal study
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009
Interleukin 6 modulates the risk to develop COPD: a prospective population-based cohort study
Source: Annual Congress 2009 - Environmental and genetic risk factors for asthma and COPD
Year: 2009
Case-control study on risk factors to COPD – does the sampling of the cases and controls affect the results?
Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD
Year: 2008
A multicentre cohort study on the association between common markers of asthma and the incidence of COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 295s
Year: 2006
Prevalence and clinical predictors of inhaler discordance in COPD: an observational study
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020
Surfactant protein D is a causal risk factor for COPD: results of Mendelian randomisation
Source: Eur Respir J, 50 (5) 1700657; 10.1183/13993003.00657-2017
Year: 2017
Genetically increased circulating FUT3 level leads to reduced risk of idiopathic pulmonary fibrosis: a Mendelian randomisation study
Source: Eur Respir J, 59 (2) 2003979; 10.1183/13993003.03979-2020
Year: 2022
C-reactive protein serum levels, genotypes and the risk of COPD. The Rotterdam study
Source: Annual Congress 2008 - Genetic risk factors for asthma and COPD
Year: 2008
Breastfeeding and the risk of childhood asthma: a population-based cohort study
Source: Annual Congress 2008 - Early life risk factors for childhood asthma: evidence from birth cohort studies I
Year: 2008
C-reactive protein levels and the risk of COPD in a general population: the Rotterdam study
Source: Annual Congress 2007 - Mechanisms and new treatments of COPD
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept